Home NDC 51352-189 PANCOLD A
Product NDC 51352-189
11-digit product format 513520189
Labeler code 51352
Product ID 51352-189_451b96c1-db6d-b777-e063-6394a90a7bef
Type HUMAN OTC DRUG
Nonproprietary name Acetaminophen, Guaifenesin, Pentoxyverine citrate, Phenylpehrine Hydcrochloride, Chlorpheniramine Maleate, Caffeine Anhydrous
Dosage form LIQUID
Route ORAL
Labeler DONGWHA PHARM. CO. LTD.
Application M012
Marketing category OTC MONOGRAPH DRUG
Marketing start 2023-07-01
Marketing end 2028-06-04
Substance PENTOXYVERINE CITRATE; ACETAMINOPHEN; GUAIFENESIN; CHLORPHENIRAMINE MALEATE; CAFFEINE; PHENYLEPHRINE HYDROCHLORIDE
Active strength 15; 300; 80; 2.5; 30; 10 mg/30mL; mg/30mL; mg/30mL; mg/30mL; mg/30mL; mg/30mL
Pharmacologic classes Adrenergic alpha1-Agonists [MoA], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Increased Respiratory Secretions [PE], Methylxanthine [EPC], Xanthines [CS], alpha-1 Adrenergic Agonist [EPC]
NDC exclude flag No
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 9 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base PANCOLD A Active Ingredients# Ingredient, Strength table Ingredient Strength PENTOXYVERINE CITRATE 15 mg/30mL ACETAMINOPHEN 300 mg/30mL GUAIFENESIN 80 mg/30mL CHLORPHENIRAMINE MALEATE 2.5 mg/30mL CAFFEINE 30 mg/30mL PHENYLEPHRINE HYDROCHLORIDE 10 mg/30mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 6 matching rows.
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 51352-189 PANCOLD A (ACETAMINOPHEN, GUAIFENESIN, PENTOXYVERINE CITRATE, PHENYLPEHRINE HYDCROCHLORIDE, CHLORPHENIRAMINE MALEATE, CAFFEINE ANHYDROUS) LIQUID [DONGWHA PHARM. CO. LTD.] 14 Current NDC, 4 package rows 20241212_fc8f1807-d344-ccc2-e053-6294a90a5089.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 74 of 180 · 3,583 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 51352-189-73 51352018973 3 BOTTLE in 1 CASE (51352-189-73) / 30 mL in 1 BOTTLE 3 bottle 2023-07-01 2028-06-04 No No Historical 51352-189-75 51352018975 30 mL in 1 BOTTLE 30 ml Historical